Plasma expression levels of microRNA-101 are downregulated in patients with Parkinson’s disease
Open Access
- 10 December 2025
- journal article
- research article
- Published by Springer Nature in BMC Research Notes
- Vol. 19 (1)
Abstract
Objective: Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the loss of dopaminergic neurons. Endoplasmic reticulum (ER) stress contributes to PD pathogenesis, with the ER-associated degradation (ERAD) system playing a protective role. HRD1, an ER-resident ubiquitin ligase, and its stabilizer SEL1L are involved in ERAD and neuronal survival. This study investigated alterations in the plasma levels of microRNA-101 (miR-101), which targets SEL1L, in patients with PD, and its potential role as a biomarker. Results: Plasma miR-101 levels in patients with PD significantly decreased compared with those in healthy controls. Receiver operating characteristic curve analysis demonstrated that miR-101 could moderately discriminate patients with PD from healthy individuals (area under the curve = 0.781, 95% confidence interval = 0.547–1.00). The optimal cutoff, as determined by the Youden index, was 0.737 (expression ratio relative to that in the healthy control group), yielding a sensitivity of 50% and specificity of 100%. These results suggested that reduced plasma miR-101 expression may reflect the pathophysiological state of PD, and miR-101 has potential as minimally invasive biomarker for PD.Keywords
Funding Information
- Japan Society for the Promotion of Science (20K07154)
- Japan Science and Technology Agency (JPMJFS2126)
This publication has 31 references indexed in Scilit:
- 2021 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2021
- Endoplasmic reticulum stress, an important factor in the development of Parkinson’s diseaseToxicology Letters, 2020
- Ubiquitin ligase HMG-CoA reductase degradation 1 (HRD1) prevents cell death in a cellular model of Parkinson's diseaseBiochemical and Biophysical Research Communications, 2018
- El modelo de 6-hidroxidopamina y la fisiopatología parkinsoniana: nuevos hallazgos en un viejo modeloNeurología, 2017
- Understanding Dopaminergic Cell Death Pathways in Parkinson DiseaseNeuron, 2016
- Pharmacological Treatment of Parkinson DiseaseJAMA, 2014
- Body mass index in Parkinson’s disease: A meta-analysisParkinsonism & Related Disorders, 2012
- Immunohistochemical localization of a ubiquitin ligase HRD1 in murine brainJournal of Neuroscience Research, 2008
- Human HRD1 protects against ER stress‐induced apoptosis through ER‐associated degradation1FEBS Letters, 2002
- An Unfolded Putative Transmembrane Polypeptide, which Can Lead to Endoplasmic Reticulum Stress, Is a Substrate of ParkinCell, 2001